• News
  • SAN DIEGO
  • Finance

Daily Digest

The Daily Digest intends to help readers track major announcements made by and about companies on the San Diego Stock Exchange Index. The Daily Digest tracks announcements and SEC filings released from midnight until 4 p.m., or three hours after the stock markets close. To see how companies on the San Diego Stock Exchange Index performed, visit sddt.com/stocks.

Acadia Pharmaceuticals Inc.: Company announced it is hosting a conference call and webcast to discuss its top-line results from its Phase III trial with pimavanserin in patients with Parkinsonís disease psychosis.

AMN Healthcare Services Inc.: SEC documents showed Vice President Denise Jackson exercised options on 7,500 shares at $9.68 per share, and sold 7,284 shares at $10.75 per share on Nov. 21.

Digirad Corp.: SEC documents showed: Director Charles Gillman purchased 15,000 shares at $2.02 to $2.08 per share between Nov. 21-26; and Director Jeffrey Eberwein purchased 15,000 shares at $2.02 to $2.08 per share between Nov. 21-26.

Illumina Inc.: Company was downgraded to “neutral” from “outperform” by brokerage firm Robert W. Baird & Co.

Inovio Pharmaceuticals Inc.: Company announced that testing of multiple synthetic vaccine constructs for cytomegalovirus induced robust T cells in mice.

Life Technologies Corp.: SEC documents showed Chairman of the Board Gregory Lucier exercised options on 161,942 shares at $0 per share, and surrendered 75,595 shares at $49.22 per share on Nov. 21.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

Subscribe Today!